Literature DB >> 12094491

[Intraureterocele transitional tumor synchronous with contralateral ureteral tumor: obstructive uropathy in panurothelial disease].

Julián García Ligero1, Jacinto Navas Pastor, Felipe García García, Andrés Sempere Gutiérrez, José Luis Rico Galiano, Mariano Tomás Ros, Luis Oscar Fontana Compiano.   

Abstract

OBJECTIVE: To present a case of urothelial tumor inside a simple ureterocele with a coexisting contralateral tumor that caused bilateral obstructive uropathy.
METHODS: Follow-up evaluation of a 74-year-old male patient with superficial tumor of the urinary bladder diagnosed 4 years earlier, revealed renal failure and bilateral obstructive uropathy. The complementary tests showed a simple left ureterocele containing a lesion suggestive of a tumor and a right ureteral tumor.
RESULTS: After biopsy confirmed coexisting urothelial disease at 3 levels (intraureterocele, contralateral ureter and in situ carcinoma of the bladder), the patient was submitted to cystoprostatectomy, nephroureterectomy and en bloc segmental ureterectomy.
CONCLUSIONS: Multicentric synchronous urothelial tumors warrant a close and long follow-up of the entire urinary tract. Among the possible sites of presentation, few cases of tumors inside a ureterocele have been reported. The case described herein, with this uncommon site of presentation, is an example of panurothelial disease.

Entities:  

Mesh:

Year:  2002        PMID: 12094491

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  2 in total

1.  Ureterocele urothelial carcinoma: managing a rare presentation.

Authors:  Juan Carlos Astigueta; Milagros Abad-Licham; Eloy Silva; Víctor Alvarez; Francis Piccone; Enrique Cruz; Joan Palou Redorta
Journal:  Ecancermedicalscience       Date:  2016-02-16

2.  A solitary urothelial tumor arising from one of bilateral ureteroceles.

Authors:  Yu Xi Terence Law; Irfan Khan Sagir; Guan Lim Lincoln Tan
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.